Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Arcutis Biotherapeutics, Inc. (ARQT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Edwards Larry Todd (Chief Commercial Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 60,000 shares
@ $0
Granted 240,000 options to buy
@ $5.58, valued at
$1.3M
|
|
| 10/03/2023 |
3
| Edwards Larry Todd (Chief Commercial Officer) has filed a Form 3 on Arcutis Biotherapeutics, Inc. |
| 08/22/2023 |
4
| Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 300 shares
@ $7.05, valued at
$2.1k
Sold 1,305 shares
@ $7.04, valued at
$9.2k
|
|
| 06/02/2023 |
4
| Matsuda Masaru (See Remark) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,875 shares
@ $0
Sold 1,830 shares
@ $7.8023, valued at
$14.3k
Granted 1,463 shares
@ $6.38, valued at
$9.3k
|
|
| 06/02/2023 |
4
| LIN SUE-JEAN (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 06/02/2023 |
4
| Heron Patrick J (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 06/02/2023 |
4
| CHAUDHURI BHASKAR (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 06/02/2023 |
4
| Curran Terrie (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 06/02/2023 |
4
| Gilbert Halley E (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 06/02/2023 |
4
| Leonard Keith R (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 06/02/2023 |
4
| Krishnamohan Neha (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 06/02/2023 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2023 |
4/A
| Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 232,000 options to buy
@ $15.82, valued at
$3.7M
|
|
| 03/08/2023 |
4
| Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,435 shares
@ $15.2638, valued at
$37.2k
|
|
| 03/08/2023 |
4
| Burrows Scott L (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 291 shares
@ $15.2634, valued at
$4.4k
|
|
| 03/08/2023 |
4
| Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 851 shares
@ $15.2634, valued at
$13k
|
|
| 03/08/2023 |
4
| Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 831 shares
@ $15.2635, valued at
$12.7k
|
|
| 03/08/2023 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 690 shares
@ $15.2634, valued at
$10.5k
|
|
| 03/08/2023 |
4
| Lock Kenneth A. (Chief Commercial Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 831 shares
@ $15.2636, valued at
$12.7k
|
|
| 03/06/2023 |
4
| Burrows Scott L (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 21,000 shares
@ $0
Granted 55,800 options to buy
@ $15.82, valued at
$882.8k
|
|
| 03/06/2023 |
4
| Lock Kenneth A. (Chief Commercial Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 21,000 shares
@ $0
Granted 55,800 options to buy
@ $15.82, valued at
$882.8k
|
|
| 03/06/2023 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 14,900 shares
@ $0
Granted 39,500 options to buy
@ $15.82, valued at
$624.9k
|
|
| 03/06/2023 |
4
| Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 18,000 shares
@ $0
Granted 47,600 options to buy
@ $15.82, valued at
$753k
|
|
| 03/06/2023 |
4
| Moore Matthew Richard (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,589 shares
@ $15.8177, valued at
$25.1k
Sold 21 shares
@ $16.52, valued at
$346.9
Granted 14,900 shares
@ $0
Granted 39,500 options to buy
@ $15.82, valued at
$624.9k
|
|
| 03/06/2023 |
4
| Matsuda Masaru (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,416 shares
@ $15.8181, valued at
$22.4k
Sold 18 shares
@ $16.52, valued at
$297.4
Granted 21,000 shares
@ $0
Granted 55,800 options to buy
@ $15.82, valued at
$882.8k
|
|
| 03/06/2023 |
4
| Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,728 shares
@ $15.8178, valued at
$27.3k
Sold 23 shares
@ $16.52, valued at
$380
Granted 21,000 shares
@ $0
Granted 55,800 options to buy
@ $15.82, valued at
$882.8k
|
|
| 03/02/2023 |
4
| Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 936 shares
@ $16.1663, valued at
$15.1k
Sold 1,414 shares
@ $15.8183, valued at
$22.4k
Sold 18 shares
@ $16.52, valued at
$297.4 |
|
| 03/02/2023 |
4
| Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,343 shares
@ $16.1663, valued at
$37.9k
Sold 5,403 shares
@ $15.8182, valued at
$85.5k
Sold 69 shares
@ $16.52, valued at
$1.1k
|
|
| 03/02/2023 |
4
| Burrows Scott L (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 416 shares
@ $16.1663, valued at
$6.7k
Sold 1,416 shares
@ $15.8183, valued at
$22.4k
Sold 18 shares
@ $16.52, valued at
$297.4 |
|
| 03/02/2023 |
4
| Lock Kenneth A. (Chief Commercial Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 936 shares
@ $16.1663, valued at
$15.1k
Sold 1,414 shares
@ $15.8182, valued at
$22.4k
Sold 18 shares
@ $16.52, valued at
$297.4 |
|
| 03/02/2023 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 792 shares
@ $16.1663, valued at
$12.8k
Sold 1,198 shares
@ $15.8185, valued at
$19k
Sold 15 shares
@ $16.52, valued at
$247.8 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|